Literature DB >> 33704634

Risk factors for COVID-19 diagnosis, hospitalization, and subsequent all-cause mortality in Sweden: a nationwide study.

Jonathan Bergman1, Marcel Ballin1,2, Anna Nordström2,3, Peter Nordström4.   

Abstract

We conducted a nationwide, registry-based study to investigate the importance of 34 potential risk factors for coronavirus disease 2019 (COVID-19) diagnosis, hospitalization (with or without intensive care unit [ICU] admission), and subsequent all-cause mortality. The study population comprised all COVID-19 cases confirmed in Sweden by mid-September 2020 (68,575 non-hospitalized, 2494 ICU hospitalized, and 13,589 non-ICU hospitalized) and 434,081 randomly sampled general-population controls. Older age was the strongest risk factor for hospitalization, although the odds of ICU hospitalization decreased after 60-69 years and, after controlling for other risk factors, the odds of non-ICU hospitalization showed no trend after 40-49 years. Residence in a long-term care facility was associated with non-ICU hospitalization. Male sex and the presence of at least one investigated comorbidity or prescription medication were associated with both ICU and non-ICU hospitalization. Three comorbidities associated with both ICU and non-ICU hospitalization were asthma, hypertension, and Down syndrome. History of cancer was not associated with COVID-19 hospitalization, but cancer in the past year was associated with non-ICU hospitalization, after controlling for other risk factors. Cardiovascular disease was weakly associated with non-ICU hospitalization for COVID-19, but not with ICU hospitalization, after adjustment for other risk factors. Excess mortality was observed in both hospitalized and non-hospitalized COVID-19 cases. These results confirm that severe COVID-19 is related to age, sex, and comorbidity in general. The study provides new evidence that hypertension, asthma, Down syndrome, and residence in a long-term care facility are associated with severe COVID-19.

Entities:  

Keywords:  COVID-19; Case–control study; Cohort study; Coronavirus; Epidemiology; SARS-CoV-2

Year:  2021        PMID: 33704634      PMCID: PMC7946619          DOI: 10.1007/s10654-021-00732-w

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  1 in total

1.  England and Wales see 20 000 excess deaths in care homes.

Authors:  Talha Burki
Journal:  Lancet       Date:  2020-05-23       Impact factor: 79.321

  1 in total
  27 in total

1.  Mental and neurological disorders and risk of COVID-19 susceptibility, illness severity and mortality: A systematic review, meta-analysis and call for action.

Authors:  Lin Liu; Shu-Yu Ni; Wei Yan; Qing-Dong Lu; Yi-Miao Zhao; Ying-Ying Xu; Huan Mei; Le Shi; Kai Yuan; Ying Han; Jia-Hui Deng; Yan-Kun Sun; Shi-Qiu Meng; Zheng-Dong Jiang; Na Zeng; Jian-Yu Que; Yong-Bo Zheng; Bei-Ni Yang; Yi-Miao Gong; Arun V Ravindran; Thomas Kosten; Yun Kwok Wing; Xiang-Dong Tang; Jun-Liang Yuan; Ping Wu; Jie Shi; Yan-Ping Bao; Lin Lu
Journal:  EClinicalMedicine       Date:  2021-09-08

2.  Association of Household Deprivation, Comorbidities, and COVID-19 Hospitalization in Children in Germany, January 2020 to July 2021.

Authors:  Nico Dragano; Olga Dortmann; Jörg Timm; Matthias Mohrmann; Rosemarie Wehner; Christoph J Rupprecht; Maria Scheider; Ertan Mayatepek; Morten Wahrendorf
Journal:  JAMA Netw Open       Date:  2022-10-03

3.  Effects of SARS-CoV-2 infections in patients with cancer on mortality, ICU admission and incidence: a systematic review with meta-analysis involving 709,908 participants and 31,732 cancer patients.

Authors:  Mehmet Emin Arayici; Nazlican Kipcak; Ufuktan Kayacik; Cansu Kelbat; Deniz Keskin; Muhammed Emin Kilicarslan; Ahmet Veli Kilinc; Sumeyye Kirgoz; Anil Kirilmaz; Melih Alihan Kizilkaya; Irem Gaye Kizmaz; Enes Berkin Kocak; Enver Kochan; Begum Kocpinar; Fatmanur Kordon; Batuhan Kurt; Hulya Ellidokuz
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-13       Impact factor: 4.322

4.  Chronic respiratory diseases are predictors of severe outcome in COVID-19 hospitalised patients: a nationwide study.

Authors:  Guillaume Beltramo; Jonathan Cottenet; Anne-Sophie Mariet; Marjolaine Georges; Lionel Piroth; Pascale Tubert-Bitter; Philippe Bonniaud; Catherine Quantin
Journal:  Eur Respir J       Date:  2021-12-09       Impact factor: 16.671

5.  COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology.

Authors:  M Puig-Domingo; M Marazuela; B O Yildiz; A Giustina
Journal:  Endocrine       Date:  2021-05-08       Impact factor: 3.633

6.  Occupation and COVID-19 diagnosis, hospitalisation and ICU admission among foreign-born and Swedish-born employees: a register-based study.

Authors:  Chioma Adanma Nwaru; Ailiana Santosa; Stefan Franzén; Fredrik Nyberg
Journal:  J Epidemiol Community Health       Date:  2022-01-07       Impact factor: 3.710

7.  Excess Mortality After COVID-19 in Swedish Long-Term Care Facilities.

Authors:  Marcel Ballin; Jonathan Bergman; Miia Kivipelto; Anna Nordström; Peter Nordström
Journal:  J Am Med Dir Assoc       Date:  2021-06-24       Impact factor: 4.669

8.  Body mass index and Mini Nutritional Assessment-Short Form as predictors of in-geriatric hospital mortality in older adults with COVID-19.

Authors:  L Kananen; M Eriksdotter; A M Boström; M Kivipelto; M Annetorp; C Metzner; V Bäck Jerlardtz; M Engström; P Johnson; L G Lundberg; E Åkesson; C Sühl Öberg; S Hägg; D Religa; J Jylhävä; T Cederholm
Journal:  Clin Nutr       Date:  2021-07-29       Impact factor: 7.324

9.  Asthma and COVID-19 risk: a systematic review and meta-analysis.

Authors:  Anthony P Sunjaya; Sabine M Allida; Gian Luca Di Tanna; Christine R Jenkins
Journal:  Eur Respir J       Date:  2022-03-31       Impact factor: 16.671

10.  Spatial clustering and contextual factors associated with hospitalisation and deaths due to COVID-19 in Sweden: a geospatial nationwide ecological study.

Authors:  Osvaldo Fonseca-Rodríguez; Per E Gustafsson; Miguel San Sebastián; Anne-Marie Fors Connolly
Journal:  BMJ Glob Health       Date:  2021-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.